Redefining salvage in free flap breast reconstruction: Long-term breast volume symmetry after re-exploration
Journal of Plastic, Reconstructive & Aesthetic Surgery · 2026
DOI: 10.1016/j.bjps.2026.02.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Plastic, Reconstructive & Aesthetic Surgery, 2026. Verfasst von Chika Gon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Reconstructive Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan; Department …. Hauptthemen laut MEDLINE: Mammaplasty, Free Tissue Flaps, Reoperation, Salvage Therapy. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Little is known about long-term esthetic outcomes after re-exploration for microvascular compromise in autologous breast reconstruction. We assessed long-term breast volume symmetry and introduced a symmetry-based "true salvage rate". METHODS: We retrospectively reviewed 727 consecutive free-flap breast reconstructions between 2017 and 2022. Among them, 26 patients experienced microvascular compromise and underwent takeback surgery. Postoperative breast volume was measured using 3D surface imaging at ≥12 months. Volume symmetry was defined as salvaged/contralateral volume ratio and graded by volume reduction: Grade 0: 50%. The "true salvage rate" was defined as the proportion of all re-explored cases that achieved Grade 0-2 at ≥12 months. RESULTS: Sixteen flaps survived (61.5%). Amongst salvaged flap cases (n=16), the median volume ratio was 0.96 (IQR 0.69-1.15); 11/16 demonstrated Grade 0-2, 3/16 Grade 3, and 2/16 Grade 4. Considering all re-explored cases, the true salvage rate was 11/26 (42.3%). Grade 0-2 asymmetry occurred in 6/7 cases when the flap was salvaged within 24 h, versus 3/5 at 24-48 h and 2/4 after 48 h. Severe asymmetry was more frequent after 48 h. CONCLUSIONS: Re-exploration for microvascular compromise may be associated with favorable long-term esthetic outcomes, particularly when performed within 24 h. A symmetry-based true salvage rate can complement conventional flap survival and provide an objective, patient-centered endpoint for counseling and quality assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Plastic and Reconstructive Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan; Department of Plastic, Reconstructive and Aesthetic Surgery, Nippon Medical Schoo…
- Department of Plastic and Reconstructive Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
- Department of Plastic and Reconstructive Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan; Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan…
- Department of Plastic, Reconstructive and Aesthetic Surgery, Nippon Medical School, Tokyo, Japan.
- Department of Plastic and Reconstructive Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. Electronic address: yuyuma.fuse@gmail.com.
Zitieren
APA
Gon, C., Karakawa, R., Yoshimatsu, H., Yano, T., Ogawa, R., & Fuse, Y. (2026). Redefining salvage in free flap breast reconstruction: Long-term breast volume symmetry after re-exploration. Journal of Plastic, Reconstructive & Aesthetic Surgery. https://doi.org/10.1016/j.bjps.2026.02.019
Vancouver
Gon C, Karakawa R, Yoshimatsu H, Yano T, Ogawa R, Fuse Y. Redefining salvage in free flap breast reconstruction: Long-term breast volume symmetry after re-exploration. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2026. doi:10.1016/j.bjps.2026.02.019
BibTeX
@article{Gon2026,
author = {Gon, Chika and Karakawa, Ryo and Yoshimatsu, Hidehiko and Yano, Tomoyuki and Ogawa, Rei and Fuse, Yuma},
title = {Redefining salvage in free flap breast reconstruction: Long-term breast volume symmetry after re-exploration},
journal = {Journal of Plastic, Reconstructive & Aesthetic Surgery},
year = {2026},
doi = {10.1016/j.bjps.2026.02.019}
}
EUVIMED